SEARCH
= Registered usersMetformin improves cardiovascular outcomes in high-risk patients.Practitioner 2013; 257 (1757): 8
Metformin improves cardiovascular outcomes in high-risk patients
28 Jan 2013
Treatment with metformin for three years produced a marked reduction in macrovascular complications and mortality compared with glipizide in patients with type 2 diabetes and coronary artery disease (CAD), a recent trial has shown.
This article can be accessed only if you are a paid-up subscriber to The Practitioner.